GNAZ Regulates PI3K/AKT/mTOR Signaling, Reversing Sorafenib Resistance in Hepatocellular Carcinoma (GNAZ 调节 PI3K/AKT/mTOR 信号传导，逆转肝细胞癌对索拉非尼的耐药性)

Authors: jian Huang, Xiaomei Chen, Tianxin Luo et al.
Publication:
Published: Unknown date
Source: Crossref
Back to Search View Original Cite This Article

Related Articles

<b>Myeloid-specific heparanase aggravates insulitis in type 1 diabetes via heparan sulfate fragments-dependent amplification of macrophage polarization</b>

Jia Zhang, Meiwei Li et al. - Unknown

Read More
A probabilistic residual-strength state-mapping framework for fatigue-life prediction of composite laminates under block loading

Zihao Feng, Xianghui Zheng et al. - Unknown

Read More
Encoding Intermittent Parathyroid Hormone Signals in Stem Cell Exosomes Enables Targeted Repair of Osteoporotic Bone Defects

Jiaqi Fang, Yiqing Wu et al. - Unknown

Read More
Racial disparities in survival among patients with pulmonary neuroendocrine tumors: a population–based cohort study

Yiming Chen, Qinzhao Huang et al. - Unknown

Read More
Systematic modeling of phenotypic drug response profiles in patient-derived organoids

Seungil Kim, Einar Bjarki Gunnarsson et al. - Unknown

Read More
Journal Ideas PyMinds Charcha More
PORE

About

About Us

Resources

Help Centre Research Guides CiteScore

Legal

Terms of Service Privacy Policy Cookie Policy Accessibility

Connect

Contact Us
© 2026 PORE. Content available under CC BY-NC 4.0